 |
| Stone & Magnanini News |
 |
New False Claims and Complex Commercial Litigation Firm
Formed by David S. Stone and Robert A. Magnanini – Stone & Magnanini LLP
NEW FIRM WILL EXPAND SUCCESSFUL AND PROFITABLE QUI TAM PRACTICE
Short Hills, NJ, March 5, 2009 – David S. Stone and Robert A. Magnanini, former partners at Boies, Schiller & Flexner LLP, announced today that they have joined forces to create Stone & Magnanini LLP. The firm, with offices in New Jersey and New York, will be a national leader in plaintiff’s complex commercial litigation, including False Claims Act cases. Eric Jaso, former Justice Department official and federal prosecutor, will also join Stone & Magnanini in the position of counsel. |
Federal court unseals Baycol whistleblower complaint against Bayer
Short Hills, NJ, April 24, 2008 - The law firm of Boies, Schiller & Flexner LLP announced that on Thursday, April 24 a federal court in Newark, New Jersey unsealed a whistleblower complaint against Bayer Healthcare Pharmaceuticals, Bayer Pharmaceuticals Corp., Bayer Corporation, and Bayer A.G., for violations of federal and state False Claims Acts. |
Team led by David Stone of BSF and the U.S. Government Settle $499 Million False Claims Act Case Against Bristol-Myers Squibb Company and Apothecon, Inc.
Short Hills, NJ, September 28, 2007, Boies, Schiller & Flexner LLP and the United States Government in conjunction with various other Relators and their counsel have announced a comprehensive $499 million settlement of several False Claims Act cases against Bristol-Myers Squibb Company (“BMS”) of New York, NY and Apothecon, a wholly-owned subsidiary of BMS. |
Team led by David Stone of BSF and the U.S. Government Settle $155 Million False Claims Act Case Against Medco Health Solutions
Short Hills, NJ, November 1, 2006, – Boies, Schiller & Flexner, LLP, and the United States Government have announced a $155 million settlement of a False Claims Act case against Medco Health Solutions, Inc. (“Medco”) of Franklin Lakes, New Jersey. |
Taxpayers
Against Fraud Conference 2005
The False Claims Act (“FCA”)
limits standing to one relator for each claim alleged in a false
claims lawsuit. 31 U.S.C. §3730(b)(5). Historically, disputes
between relators on standing issues were set aside until the
lawsuit neared resolution. |
Taxpayer’s
Against Fraud Seminar-Recent Developments in the Law
The Public Disclosure Bar and the Original Source Exception |
Team led by David Stone of BSF joins government's False Claims Act case against Medco
David Boies, Chairman of Boies, Schiller & Flexner LLP, announced today that his firm has agreed to represent one of the relators in the United States' Federal False Claims Act lawsuit against Medco Health Solutions Inc. |
October
14, 2004: David Stone addresses the annual convention of Taxpayers
Against Fraud
(TAF).
At the TAF Education Fund two-day conference in October, 2004, David Stone was the principal speaker in a session entitled "Assessing and Proving Damages for Settlement and Trial in a Healthcare False Claims Act Case," part of a series of talks and discussions centered on false claims/qui tam case practice. |
|
|
